Mergers and acquisitions – as goliath takes over david – are the risks worth it?
Today’s mergers and acquisitions landscape involves more transactions between companies of difference in sizes (in terms of assets,
29 July 2024
Today’s mergers and acquisitions landscape involves more transactions between companies of difference in sizes (in terms of assets,
29 July 2024
Investments in the life science and pharmaceutical industries are a different ballgame.
25 July 2024
Pharmaceutical companies that plan launches of prescription-only medicines need to be aware: there are regulatory matters in Singapore things which can interrupt your launch if they’re not sufficiently attended to.
08 July 2024
It should come as no surprise that the marketing of pharmaceutical products is regulated – and that even advertisements of such products are regulated.
04 July 2024
AI
The UK Supreme Court held, on 20 December 2023, that an AI system could NOT be an inventor for two UK Patent applications.
14 March 2024